Oncology Flashcards
CRITERIA SUGGESTIVE OF HEREDITARY CANCER
- Tumor development at a much younger age than usual 2. Presence of bilateral disease 3. Presence of multiple primary malignancies 4. Presentation of a cancer in less than affected sex. 5. Clustering of the same cancer type in relatives 6. Cancer associated with other conditions such as mental retardation and pathognomic skin lesion
the gene mutated in multiple advanced cancers 1
PTEN
Metastases diagnosed at the initial cancer diagnosis
SYNCHRONOUS METASTASES
Activating mutations in BRAF causes:
Melanoma Sporadic colorectal cancer Papillary thyroid cancer
angiogenic oncogenes and tumor-suppressor genes
Ras Myc HER2/ neu p53
viral DNA can be integrated into the cellular chromosomal DNA, leading to transformation of cells to a neoplastic state
Non Permissive Host
Breast self-examination
Monthly, starting at age 20
Cells present in the blood that possess antigenic or genetic characteristics of a specific tumor type
CA – CIRCULATING TUMOR CELLS
PTEN ((phosphatase and tensin homologue)
Cowden Disease (multiple hamartoma syndrome)
Encodes for the human homologue of the yeast Cds1 and the RAD53 G2 checkpoint, whose activation by DNA damage prevents entry into mitosis
hCHK2 gene
Disappearance of disease and no evidence of new for a specified interval of 4 weeks
Complete response
Is a tumor related antigen that is elevated in colon and pancreatic ca; Measured at the start of therapy and every 1-3 mos while under treatment
CA 19-9
Step in Tumorigenesis that may lead a single cell to acquire a distinct growth advantage
Initiation
2 types of oncogenes
Growth Factors Growth Factor Receptors
other names for gene p16
INK4A, CDKN1, CDKN2A, and MTS1
3 groups of chemical carcinogens
- Genotoxins 2. Co-carcinogens 3. Tumor promoters
irradiated cells secrete cytokines and other factors that increase production of reactive oxygen species in bystander cells, may involve cell to cell communication via gap junction
“By stander effect”
Tumor cell-cycle regulators (in human) which are frequently mutated or altered in expression:
INK4a INK4b KIP1
Major cellular pathway for protein and organelle turnover
Autophagy
Progression step in tumorigenesis
Repeated promoter application to acquire spontaneous mutation
hereditary predisposition for colorectal cancer with early age of onset and an excess of synchronous and metachronous colonic cancers
Lynch 1
Tamoxifen
Endometrial CA
5q Mutation
FAP (Familial Adenomatous Polyposis)
A genetically regulated program to dispose of cells
Apoptosis
What are the types of Adjuvant Therapy?
Chemotherapy Hormonal therapy Immuno-therapy Biologic therapy Radiation Therapy
What is formed when ligands are bound to the receptors
DISC (Death Inducing Signal Complex)
50% or more decrease of the original size, determined by two observations (not less than 4 weeks apart); No appearance or progress of new lesion progression of any lesion demonstrated
Partial Response
Benzene, Chlorambucil
Leukemia
infection with an oncogenic DNA virus result in a productive lytic infection, leading to cell death and release of newly formed viruses
Permissive Host
Ubiquitous proteins that are produced and secreted by cells locally which stimulates cell proliferation
Growth factors
Steps in Tumorigenisis
Initiation Promotion Progression
Types of Alkylating Agents
- Classic alkylators 2. Nitrosoureas 3. Miscellaneous DNA-binding agents
Two types of epidemiological studies that are done most commonly
Cohort Study Case-control Study
Glycoprotein encoded by MUC1 gene that tumor cells shed into the blood stream and useful in diagnosis of advanced breast CA
CA15-3
Antitumor Antibiotic
Bleomycin
Tumor suppressor that acts by binding CDK4 and CDK6 and inhibiting the catalytic activity of the CDK4-CDK6/cyclin D complex
p16
CEA (Carcinoembryonic Antigen) is elevated specially in?
colon cancer
Anti-metabolites
Folate analogues Methotrexate Purine analogues Azathioprine Mercaptopurine Thioguanine Cladibrine (2-chlorodeoxyadenosine) Fludarabine Pentostatin Pyrimidine analogues Capecitabine Cytarabine Floxuridine Gemcitabine Ribonucleotide reductase inhibitors Hydroxyurea
25% or greater increase in size or appearance of new lesions
Progressive
Classifications of Biopsy
- Mucosal biopsy via endoscopic exam 2. Palpable external lesions a. Needle biopsy - Fine needle biopsy - Core needle biopsy 3. Open biopsy (When needle biopsy is questionable) - Incision biopsy - Excision biopsy
Breast Cancer Global Statistics
2ND LEADING CANCER IN THE WORLD 5th MOST COMMON CAUSE OF CANCER DEATH
Physical Carcinogens cause cancer either by:
a. Induction of inflammation and cell proliferation b. Exposure induces DNA damages and mutation
Administration before surgery of tumor considered initially inoperable
preoperative chemotherapy, neoadjuvant chemotherapy, or induction therapy
hMLH1; hMSH2; hMSH6;PMS1; hPMS2
Hereditary nonpolyposis colorectal cancer
What is the primary goal of PRIMARY / DEFINITIVE THERAPY?
Local and regional control of cancer
Block caspase 3 activation
Inhibitors of Apoptosis Proteins (IAPs)
rb
Retinoblastoma
Uses of Cancer Staging
- Selection of therapy – basis for selection of therapy 2. Estimation of prognosis 3. Evaluation of treatments 4. Exchange of information among tx centers 5. Continued investigation of human cancers
It is detected by staining bone marrow aspirates with monoclonal antibodies to cytokeratin.
Bone marrow Metastases
Surgical ablation of organs producing the hormones- oophorectomy for breast cancer
Hormonal Therapy
Not a single cell but rather a large number of cells in a target organ may have undergone the initiating genetic event
Field Theory
Indications for Chemotherapy
- Established / documented distant metastatic disease: 2. Therapy given for patient with high risk for distant metastasis known as adjuvant chemotherapy.
Treatment for breast cancer which work by targeting bcr-abl, c-kit, and HER2/ neu,
Trastuzumab (Herceptin)
Cells that have the ability to perpetuate themselves through self-renewal and to generate mature cells of a particular tissue through differentiation
Cancer stem cells
Benzidine
Bladder cancer
Plant Alkaloids
VInca alkaloids Vinblastine Vincristine Vindesine Vinorelbine Epipodophyllotoxins Etoposide Teniposide Taxanes Paclitaxel Docetaxel
stimulate hydrolysis of the bound GTP to return RAS to its inactive form
GTPase activating proteins (GAP’s)
Compare a group of patients affected with a disease to a group of individuals without the disease for a given exposure
Case-Conrol Study
Heat shock proteins
hsp27, hsp70
Promoters include:
Hormones Growth Factors Cytokines *Chronic Smoking
System describing the extent malignancy
Cancer Staging
Cells exhibit reduced sensitivity to drugs-by virtue of their cell cycle distribution
Kinetic Resistance
Spread from the primary site and formation of new tumor in distant sites
Metastasis
Bind to the DISC & inhibit activation of caspase 8
FADD-like interleukin-1 protease-inhibitory proteins (FLIPs)
hereditary predisposition for colorectal cancer with early age of onset and an excess of synchronous and metachronous colonic cancers and has a high risk for: carcinoma of the endometrium transitional cell carcinoma of the ureter and renal pelvis carcinomas of the stomach, small bowel, ovary, and pancreas
Lynch 2
Mechanisms of Viral Oncogenes
a. Interfere cell-cycle check points and DNA repair b. Expression of cytokines and other growth factors c. Alteration of immune system
Hepatocellular carcinoma
Hepatitis B Hepatitis C
Miscellaneous Agents
Asparaginase Estramustine Mitotane
3 stages of Adenomas:
Increase size Dysplasia Villous content
HPV type 16 and 18
Cervical cancer Anal cancer
Metastasis diagnosed after a disease-free interval
METACHRONOUS METASTASES
Nitrosoureas
Carmustine (BCNU) Lomustine (CCNU) Semustine (MeCCNU) Streptozocin
EBV (Epstein Barr Virus)
Burkitt’s lymphoma, Hodgkin’s disease Immunosuppression-related lymphoma Sinonasal angiocentric, T-cell lymphoma, Nasopharyngeal carcinoma
3rd most common cause of cancer death
Colorectal Cancer
if tumor is small, instead of removal of the whole breast, you only remove one quadrant
Conservative surgery
To induce or potentiate inherent anti-tumor immunity to destroy cancer cells
Immune therapy
Medullary thyroid carcinoma and pheochromocytoma (in 50%) or parathyroid adenoma (in 20%)
MEN2A
p53
Li-Fraumeni syndrome
Potentially best tumor marker available
PSA (Prostate Specific antigen)
Failure to kill cells is due to insufficient drug concentration occurs when tumor cells are located in sites where effective drug concentrations are difficult to achieve
Pharmacologic Resistance
The intent is not for cure because of the nature of the disease
Palliative surgery
Glycoprotein that is ideal for tumor marker
PSA (Prostate Specific antigen)